Suchergebnisse - "Christensen, Britt"

PubPharm (193)

81

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +19

82

Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19

enthalten in: Journal of Crohn's & colitis | 2020

von Siegel, C. | Christensen, B. | Kornbluth, A. | +7

83

Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Christensen, B. | Erlich, J. | Gibson, P. | +3

CommentIn: Clin Gastroenterol Hepatol. 2020 Oct;18(11):2430-2431. - PMID 32007540

84

Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes

enthalten in: Journal of Crohn's & colitis | 2020

von Christensen, B. | Hanauer, S. | Gibson, P. | +3

85

Gastrointestinal ACE2, COVID-19 and IBD : Opportunity in the Face of Tragedy?

enthalten in: Gastroenterology | 2020

von Garg, M. | Christensen, B. | Lubel, J.

CommentOn: Gastroenterology. 2020 May;158(6):1831-1833.e3. - PMID 32142773

86

Letter : Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Prentice, R. | Al-Ani, A. | Christensen, B.

CommentOn: Aliment Pharmacol Ther. 2020 Oct;52(8):1414-1415. - PMID 33105972

87

Letter : ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Prentice, R. | Tjandra, D. | Garg, M. | +5

CommentOn: Aliment Pharmacol Ther. 2020 Jul;52(2):276-283. - PMID 32359205

88

Letter : is pneumococcal vaccination safe during the COVID-19 pandemic? Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Al-Ani, A. | Johnson, D. | Christensen, B.

CommentOn: Aliment Pharmacol Ther. 2020 Sep;52(5):919-920. - PMID 32852816

89

Supplement with whey protein hydrolysate in contrast to carbohydrate supports mitochondrial adaptations in trained runners

enthalten in: Journal of the International Society of Sports Nutrition | 2020

von Hansen, M. | Oxfeldt, M. | Larsen, A. | +8

90

Letter : IBD nurse-pivotal role in the time of the pandemic. Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Al-Ani, A. | Rentsch, C. | Azim, S. | +3

CommentOn: Aliment Pharmacol Ther. 2020 Jul;52(1):54-72. - PMID 32348598